Oppenheimer & Co. Inc. Purchases 5,618 Shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Posted by MarketBeat News on Nov 20th, 2024

Oppenheimer & Co. Inc. increased its position in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 10.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 57,248 shares of the company’s stock after acquiring an additional 5,618 shares during the period. Oppenheimer & Co. Inc. owned about 0.05% of BlackRock Capital Allocation Term Trust worth $942,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Fountainhead AM LLC lifted its holdings in shares of BlackRock Capital Allocation Term Trust by 2.1% during the third quarter. Fountainhead AM LLC now owns 53,570 shares of the company’s stock worth $881,000 after purchasing an additional 1,095 shares during the period. Blue Bell Private Wealth Management LLC grew its position in shares of BlackRock Capital Allocation Term Trust by 4.0% in the 2nd quarter. Blue Bell Private Wealth Management LLC now owns 104,722 shares of the company’s stock valued at $1,718,000 after buying an additional 4,059 shares during the last quarter. Transcend Capital Advisors LLC increased its stake in shares of BlackRock Capital Allocation Term Trust by 7.3% in the second quarter. Transcend Capital Advisors LLC now owns 65,207 shares of the company’s stock valued at $1,070,000 after buying an additional 4,435 shares during the period. Cambridge Investment Research Advisors Inc. raised its position in shares of BlackRock Capital Allocation Term Trust by 4.3% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company’s stock worth $2,186,000 after acquiring an additional 5,438 shares during the last quarter. Finally, Mathes Company Inc. lifted its stake in shares of BlackRock Capital Allocation Term Trust by 6.0% in the third quarter. Mathes Company Inc. now owns 96,500 shares of the company’s stock worth $1,587,000 after acquiring an additional 5,500 shares during the period. Institutional investors and hedge funds own 36.12% of the company’s stock.

Insider Buying and Selling

In related news, major shareholder Saba Capital Management, L.P. sold 40,158 shares of the firm’s stock in a transaction that occurred on Wednesday, October 16th. The stock was sold at an average price of $16.27, for a total transaction of $653,370.66. Following the completion of the sale, the insider now owns 14,969,295 shares of the company’s stock, valued at $243,550,429.65. This trade represents a 0.27 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders sold 723,927 shares of company stock valued at $11,925,047 over the last quarter.

BlackRock Capital Allocation Term Trust Trading Down 0.2 %

Want More Great Investing Ideas?

Shares of BCAT stock opened at $16.01 on Wednesday. The business’s 50 day simple moving average is $16.27 and its 200 day simple moving average is $16.32. BlackRock Capital Allocation Term Trust has a one year low of $14.60 and a one year high of $17.18.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be given a dividend of $0.2885 per share. The ex-dividend date of this dividend is Friday, November 15th. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. This represents a $3.46 annualized dividend and a dividend yield of 21.63%.